🎓 Applications open for Academic Year 2026/27
👉 To apply, click here: → GO TO THE APPLICATION PAGE
⏳ Deadline: 14 July 2026, ore 13:00 (CEST)
The call for applications for admission to the National PhD Program in Science and Technology for Advanced Therapies (STAT) – 42nd Cycle, Academic Year 2026/2027, coordinated by Professor Annalisa Bonfiglio, has been published.
The three-year program has been designed to train a new generation of highly qualified researchers in the field of advanced therapies, capable of combining basic research, technological innovation, and clinical application.
In a context characterized by the rapid evolution of technologies applied to healthcare, life sciences, and biomedicine, the PhD program provides interdisciplinary expertise integrating medicine, biophysics, bioengineering, and biotechnology, preparing researchers to address the scientific and technological challenges of the future.
Promoted by the IUSS School for Advanced Studies Pavia in collaboration with Fondazione Telethon, the University of Pavia, and Fondazione CNAO, the program is developed within an ecosystem of excellence that integrates scientific, technological, and biomedical expertise, fostering research and the development of innovative solutions for human health.
The Three Curricula
The educational pathway is structured into three specialized curricula:
CU1 – Hadron Therapy and Advanced Biophysical Therapies
Dedicated to the study and development of non-pharmacological therapeutic technologies based on biophysical and bioengineering approaches, with particular focus on hadron therapy, advanced biomedical instrumentation, and the clinical applications of emerging technologies.
CU2 – Gene and Cell Therapies
Focused on the design, development, and clinical application of innovative gene and cell therapies, with the goal of creating new therapeutic strategies for genetic diseases and complex disorders.
CU3 – Biomolecular and Biotechnological Sciences
Oriented toward experimental research in biomolecular sciences and biotechnology, integrating disciplines such as structural biology, medicinal and bioinorganic chemistry, molecular microbiology, neuropharmacology, and molecular hematology.
The PhD program is fully aligned with the strategic priorities outlined in Italy’s National Research Program (PNR) and the National Recovery and Resilience Plan (PNRR), contributing to the strengthening of Italian research in key areas such as biotechnology, precision medicine, and advanced therapies.
Available Positions
A total of 34 positions are available, including:
- 5 positions reserved for company employees;
- 11 positions for candidates selected under the Marie Skłodowska-Curie Actions – COFUND Rarefind program, coordinated by Fondazione Telethon ETS;
- 2 positions for candidates selected under the Marie Skłodowska-Curie Actions – Doctoral Network INT2ACT program, coordinated by the University of Udine.
For detailed information on available scholarships and research projects, please refer to the "Research Programme" section.
For detailed information on available scholarships and research projects, applicants are invited to consult the Educational Programme.
How to Apply
📅 Application deadline: by 1:00 PM (CEST) on 14 July 2026.
Applications must be submitted exclusively online through the PICA platform.
A non-refundable application fee of €30 is required and must be paid by the application deadline.
Admission Requirements
Applicants must hold a Master’s Degree, an equivalent second-cycle academic qualification, or a comparable qualification obtained in Italy or abroad and deemed suitable by the Admissions Committee.
Admission to the program is subject to successful completion of the selection procedures outlined in the official call, which is also published on the website of the Italian Ministry of University and Research.
For further information about the program, curriculum, and selection procedures, please consult the official documentation or contact the PhD Office at: phd-stat@iusspavia.it.
Please refer to the call for proposals